The use of glucagon-like peptide-1 receptor agonists is likely to increase the risks of inadequate bowel preparation for colonoscopy, according to a study published Feb. 12 in The American Journal of Gastroenterology.
Here are three things to know:
1. Researchers searched several databases for data on bowel prep in GLP-1 and non-GLP-1 users.
2. After reviewing 10,833 subjects, the inadequate prep rate was higher in the GLP-1s group compared to the control group.
3. Of the patients, 5,434 were GLP-1 users and 5,399 were in the control group.
Here are 10 numbers on the gastroenterology and endoscopy workforce: 3: The number of the immediate past years that Medscape’s…
A recent study published in The Lancet found that the addition of a deadline to a mailed invitation for fecal…
U.S. News & World Report has named the 259 top ASCs for colonoscopy and endoscopy for 2025. The publication recognized…